Phase II Dose-Finding Study of SK-0403 With Type 2 Diabetes Mellitus

PHASE2CompletedINTERVENTIONAL
Timeline

Start Date

Not specified

Conditions
Type 2 Diabetes Mellitus
Interventions
DRUG

SK-0403

Trial Locations (10)

Unknown

Fukuoka

Gifu

Gunma

Hokkaido

Ibaraki

Kanagawa

Kumamoto

Okinawa

Ōita

Tokyo

All Listed Sponsors
lead

Sanwa Kagaku Kenkyusho Co., Ltd.

INDUSTRY

NCT00532506 - Phase II Dose-Finding Study of SK-0403 With Type 2 Diabetes Mellitus | Biotech Hunter | Biotech Hunter